Additional mechanisms conferring genetic susceptibility to Alzheimer’s disease

Frontiers in Cellular Neuroscience

Volumn 9, Issue APR, 2015, Pages

  Calero, Miguel ^a,b,c   Gómez Ramos, Alberto ^a,d   Calero, Olga ^a,b   Soriano, Eduardo ^a,e   Avila, Jesús ^a,d   Medina, Miguel ^a,c  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Alzheimer; Epistasis; Exome; GWAS; Neurodegeneration; Rare variants; Risk factors; Somatic mutations

Indexed keywords

ADAM10 ENDOPEPTIDASE; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CD2 ASSOCIATED PROTEIN; CD33 ANTIGEN; CLUSTERIN; DESMOGLEIN 2; EPHRIN RECEPTOR A1; FOCAL ADHESION KINASE 1; GLUTATHIONE TRANSFERASE M3; PRESENILIN 1; PRESENILIN 2; PRION PROTEIN; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ARTICLE; COPY NUMBER VARIATION; CREUTZFELDT JAKOB DISEASE; DNA DAMAGE; ENDOCYTOSIS; EPISTASIS; EXOME; GENE EXPRESSION; GENE INTERACTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INHERITANCE; NERVE DEGENERATION; NEXT GENERATION SEQUENCING; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION;

EID: 84927590047     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00138     Document Type: Article

References (87)

1. Aguzzi, A., and Rajendran, L. (2009). The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 64, 783-790. doi: 10.1016/j.neuron.2009.12.016
2. Alzualde, A., Moreno, F., Martínez-Lage, P., Ferrer, I., Gorostidi, A., Otaegui, D., et al. (2010). Somatic mosaicism in a case of apparently sporadic Creutzfeldt-Jakob disease carrying a de novo D178N mutation in the PRNP gene. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B, 1283-1291. doi: 10.1002/ajmg.b.31099
3. Ashford, J. W. (2004). APOE genotype effects on Alzheimer's disease onset and epidemiology. J. Mol. Neurosci. 23, 157-165. doi: 10.1385/JMN:23:3:157
4. Bali, J., Gheinani, A. H., Zurbriggen, S., and Rajendran, L. (2012). Role of genes linked to sporadic Alzheimer's disease risk in the production of β-amyloid peptides. Proc. Natl. Acad. Sci. U.S.A. 109, 15307-15311. doi: 10.1073/pnas.1201632109
5. Barja, G. (2004). Free radicals and aging. Trends Neurosci. 27, 595-600. doi: 10.1016/j.tins.2004.07.005
6. Beck, J. A., Poulter, M., Campbell, T. A., Uphill, J. B., Adamson, G., Geddes, J. F., et al. (2004). Somatic and germline mosaicism in sporadic early-onset Alzheimer's disease. Hum. Mol. Genet. 13, 1219-1224. doi: 10.1093/hmg/ddh134
7. Benitez, B. A., Jin, S. C., Guerreiro, R., Graham, R., Lord, J., Harold, D., et al. (2014). Missense variant in TREML2 protects against Alzheimer's disease. Neurobiol. Aging 35, 1510. doi: 10.1016/j.neurobiolaging.2013.12.010
8. ® [Internet], eds R. A. Pagon, M. P. Adam, H. H. Ardinger, T. D. Bird, C. R. Dolan, and C. T. Fong (Seattle, WA; University of Washington, Seattle), 1993-2014.
9. Blom, E. S., Viswanathan, J., Kilander, L., Helisalmi, S., Soininen, H., Lannfelt, L., et al. (2008). Low prevalence of APP duplications in Swedish and Finnish patients with early-onset Alzheimer's disease. Eur. J. Hum. Genet. 16, 171-175. doi: 10.1038/sj.ejhg.5201966
10. Bullock, J. M., Medway, C., Cortina-Borja, M., Turton, J. C., Prince, J. A., Ibrahim-Verbaas, C. A., et al. (2013). Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease. Neurobiol. Aging 34, 1309.e1-1309.e7. doi: 10.1016/j.neurobiolaging.2012.08.010
11. Calero, O., Bullido, M. J., Clarimón, J., Frank-García, A., Martínez-Martín, P., Lleó, A., et al. (2011). Genetic cross-interaction between APOE and PRNP in sporadic Alzheimer's and Creutzfeldt-Jakob diseases. PLoS ONE 6:e22090. doi: 10.1371/journal.pone.0022090
12. Cannon, T. D., and Keller, M. C. (2006). Endophenotypes in the genetic analyses of mental disorders. Annu. Rev. Clin. Psychol. 2, 267-290. doi: 10.1146/annurev.clinpsy.2.022305.095232
13. Chung, S. J., Kim, M. J., Kim, J., Kim, Y. J., You, S., Koh, J., et al. (2014). Exome array study did not identify novel variants in Alzheimer's disease. Neurobiol. Aging 35, 1958.e13-1958.e14. doi: 10.1016/j.neurobiolaging.2014.03.007
14. Combarros, O., Cortina-Borja, M., Smith, A. D., and Lehmann, D. J. (2009). Epistasis in sporadic Alzheimer's disease. Neurobiol. Aging 30, 1333-1349. doi: 10.1016/j.neurobiolaging.2007.11.027
15. Cordell, H. J. (2009). Detecting gene-gene interactions that underlie human diseases. Nat. Rev. Genet. 10, 392-404. doi: 10.1038/nrg2579
16. Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C. Jr., et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7, 180-184. doi: 10.1038/ng0694-180
17. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923. doi: 10.1126/science.8346443
18. Cruchaga, C., Karch, C. M., Jin, S. C., Benitez, B. A., Cai, Y., Guerreiro, R., et al. (2014). Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease. Nature 505, 550-554. doi: 10.1038/nature12825
19. Cuyvers, E., Bettens, K., Philtjens, S., Van Langenhove, T., Gijselinck, I., van der Zee, J., et al. (2014). Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia. Neurobiol. Aging 35, 726.e11-726.e19. doi: 10.1016/j.neurobiolaging.2013.09.009
20. Di Fede, G., Catania, M., Morbin, M., Rossi, G., Suardi, S., Mazzoleni, G., et al. (2009). A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 323, 1473-1477. doi: 10.1126/science.1168979
21. Eisenberg, D. T., Kuzawa, C. W., and Hayes, M. G. (2010). Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history. Am. J. Phys. Anthropol. 143, 100-111. doi: 10.1002/ajpa.21298
22. Frade, J. M., and López-Sánchez, N. (2010). A novel hypothesis for Alzheimer disease based on neuronal tetraploidy induced by p75 (NTR). Cell Cycle 9, 1934-1941. doi: 10.4161/cc.9.10.11582
23. Gómez-Ramos, A., Sanchez-Sanchez, R., Muhaisen, A., Rábano, A., Soriano, E., and Avila, J. (2014). Similarities and differences between exome sequences found in a variety of tissues from the same individual. PLoS ONE 9:e101412. doi: 10.1371/journal.pone.0101412
24. Guerreiro, R., Brás, J., and Hardy, J. (2013a). SnapShot: genetics of Alzheimer's disease. Cell 155, 968-968. doi: 10.1016/j.cell.2013.10.037
25. Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., et al. (2013b). TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 368, 117-127. doi: 10.1056/NEJMoa1211851
26. Guerreiro, R., Brás, J., Wojtas, A., Rademakers, R., Hardy, J., and Graff-Radford, N. (2014). A nonsense mutation in PRNP associated with clinical Alzheimer's disease. Neurobiol. Aging 35, 2656.e13-2656.e16. doi: 10.1016/j.neurobiolaging.2014.05.013
27. Guerreiro, R. J., Gustafson, D. R., and Hardy, J. (2012). The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiol. Aging 33, 437-456. doi: 10.1016/j.neurobiolaging.2010.03.025
28. Guerreiro, R., and Hardy, J. (2013). TREM2 and neurodegenerative disease. N. Engl. J. Med. 369, 1569-1570. doi: 10.1056/NEJMc1306509#SA1
29. Gusareva, E. S., Carrasquillo, M. M., Bellenguez, C., Cuyvers, E., Colon, S., Graff-Radford, N. R., et al. (2014). Genome-wide association interaction analysis for Alzheimer's disease. Neurobiol. Aging 35, 2436-2443. doi: 10.1016/j.neurobiolaging.2014.05.014
30. Hartley, D., Blumenthal, T., Carrillo, M., DiPaolo, G., Esralew, L., Gardiner, K.et al. (2014). Down syndrome and Alzheimer's disease: common pathways, common goals. Alzheimers Dement. doi: 10.1016/j.jalz.2014.10.007 [Epub ahead of print].
31. Hellenbroich, Y., Schwinger, E., and Zühlke, C. (2001). Limited somatic mosaicism for Friedreich's ataxia GAA triplet repeat expansions identified by small pool PCR in blood leukocytes. Acta Neurol. Scand. 103, 188-192. doi: 10.1034/j.1600-0404.2001.103003188.x
32. Hohman, T. J., Koran, M. E., Thornton-Wells, T., and Alzheimer's Neuroimaging Initiative. (2013). Epistatic genetic effects among Alzheimer's candidate genes. PLoS ONE 8:e80839. doi: 10.1371/journal.pone.0080839
33. Iourov, I. Y., Vorsanova, S. G., Liehr, T., and Yurov, Y. B. (2009). Aneuploidy in the normal, Alzheimer's disease and ataxia-telangiectasia brain: differential expression and pathological meaning. Neurobiol. Dis. 34, 212-220. doi: 10.1016/j.nbd.2009.01.003
34. Iourov, I. Y., Vorsanova, S. G., and Yurov, Y. B. (2013). Somatic cell genomics of brain disorders: a new opportunity to clarify genetic-environmental interactions. Cytogenet. Genome. Res. 139, 181-188. doi: 10.1159/000347053
35. Jacobs, K. B., Yeager, M., Zhou, W., Wacholder, S., Wang, Z., Rodriguez-Santiago, B., et al. (2012). Detectable clonal mosaicism and its relationship to aging and cancer. Nat. Genet. 44, 651-658. doi: 10.1038/ng.2270
36. Jeppesen, D. K., Bohr, V. A., and Stevnsner, T. (2011). DNA repair deficiency in neurodegeneration. Prog. Neurobiol. 94, 166-200. doi: 10.1016/j.pneurobio.2011.04.013
37. Jin, S. C., Pastor, P., Cooper, B., Cervantes, S., Benitez, B. A., Razquin, C., et al. (2012). Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort. Alzheimers Res. Ther. 4, 34. doi: 10.1186/alzrt137
38. Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., et al. (2012). A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 488, 96-99. doi: 10.1038/nature11283
39. Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., et al. (2013). Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 368, 107-116. doi: 10.1056/NEJMoa1211103
40. Kahlem, P., and Djian, P. (2000). The expanded CAG repeat associated with juvenile Huntington disease shows a common origin of most or all neurons and glia in human cerebrum. Neurosci. Lett. 286, 203-207. doi: 10.1016/S0304-3940(00)01029-6
41. Karch, C. M., Cruchaga, C., and Goate, A. M. (2014). Alzheimer's disease genetics: from the bench to the clinic. Neuron 83, 11-26. doi: 10.1016/j.neuron.2014.05.041
42. Karch, C. M., and Goate, A. M. (2015). Alzheimer's disease risk genes and mechanisms of disease pathogenesis. Biol. Psychiatry 77, 43-51. doi: 10.1016/j.biopsych.2014.05.006
43. Kasuga, K., Shimohata, T., Nishimura, A., Shiga, A., Mizuguchi, T., Tokunaga, J., et al. (2009). Identification of independent APP locus duplication in Japanese patients with early-onset Alzheimer disease. J. Neurol. Neurosurg. Psychiatry 80, 1050-1052. doi: 10.1136/jnnp.2008.161703
44. Kauwe, J. S., Bailey, M. H., Ridge, P. G., Perry, R., Wadsworth, M. E., Hoyt, K. L., et al. (2014). Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation. PLoS Genet. 10:e1004758. doi: 10.1371/journal.pgen.1004758
45. Kauwe, J. S., Cruchaga, C., Karch, C. M., Sadler, B., Lee, M., Mayo, K., et al. (2011). Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease. PLoS ONE 6:e15918. doi: 10.1371/journal.pone.0015918
46. Kennedy, S. R., Loeb, L. A., and Herr, A. J. (2012). Somatic mutations in aging, cancer and neurodegeneration. Mech. Ageing Dev. 133, 118-126. doi: 10.1016/j.mad.2011.10.009
47. Kim, M., Suh, J., Romano, D., Truong, M. H., Mullin, K., Hooli, B., et al. (2009). Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. Hum. Mol. Genet. 18, 3987-3996. doi: 10.1093/hmg/ddp323
48. Lambert, J. C., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013). Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 45, 1452-1458. doi: 10.1038/ng.2802
49. Le Ber, I., De Septenville, A., Guerreiro, R., Bras, J., Camuzat, A., Caroppo, P., et al. (2014). Homozygous TREM2 mutation in a family with atypical frontotemporal dementia. Neurobiol. Aging 35, 2419.e23-2419.e25. doi: 10.1016/j.neurobiolaging.2014.04.010
50. Lee, J. H., Kahn, A., Cheng, R., Reitz, C., Vardarajan, B., Lantigua, R., et al. (2014). Disease-related mutations among Caribbean Hispanics with familial dementia. Mol. Genet. Genomic Med. 2, 430-437. doi: 10.1002/mgg3.85
51. Lehmann, D. J., Schuur, M., Warden, D. R., Hammond, N., Belbin, O., Kölsch, H., et al. (2012). Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project. Neurobiol. Aging 33, 202.e1-202.e13. doi: 10.1016/j.neurobiolaging.2010.07.018
52. Logue, M. W., Schu, M., Vardarajan, B. N., Farrell, J., Bennett, D. A., Buxbaum, J. D., et al. (2014). Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans. Alzheimers Dement 10, 609-618. doi: 10.1016/j.jalz.2014.06.010
53. Lord, J., Lu, A. J., and Cruchaga, C. (2014). Identification of rare variants in Alzheimer's disease. Front. Genet. 5:369. doi: 10.3389/fgene.2014.00369
54. Lynch, M. (2010). Evolution of the mutation rate. Trends Genet. 26, 345-352. doi: 10.1016/j.tig.2010.05.003
55. Ma, L., Clark, A. G., and Keinan, A. (2013). Gene-based testing of interactions in association studies of quantitative traits. PLoS Genet. 9:e1003321. doi: 10.1371/journal.pgen.1003321
56. Mahley, R. W. (1988). Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630. doi: 10.1126/science.3283935
57. Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., et al. (2009). Finding the missing heritability of complex diseases. Nature 461, 747-753. doi: 10.1038/nature08494
58. Medawar, P. B. (1952). An Unsolved Problem of Biology. London: HK Lewis.
59. Medina, M., and Dotti, C. G. (2003). RIPped out by presenilin-dependent gamma-secretase. Cell. Signal. 15, 829-841. doi: 10.1016/S0898-6568(03)00041-X
60. Møllersen, L., Rowe, A. D., Larsen, E., Rognes, T., and Klungland, A. (2010). Continuous and periodic expansion of CAG repeats in Huntington's disease R6/1 mice. PLoS Genet. 6:e1001242. doi: 10.1371/journal.pgen.1001242
61. Muñoz-Nieto, M., Ramonet, N., López-Gastón, J. I., Cuadrado-Corrales, N., Calero, O., Díaz-Hurtado, M., et al. (2013). A novel mutation I215V in the PRNP gene associated with Creutzfeldt-Jakob and Alzheimer's diseases in three patients with divergent clinical phenotypes. J. Neurol. 260, 77-84. doi: 10.1007/s00415-012-6588-1
62. Naj, A. C., Jun, G., Reitz, C., Kunkle, B. W., Perry, W., Park, Y. S., et al. (2014). Effects of multiple genetic Loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol. 71, 1394-1404. doi: 10.1001/jamaneurol.2014.1491
63. Parcerisas, A., Rubio, S. E., Muhaisen, A., Gómez-Ramos, A., Pujadas, L., Puiggros, M., et al. (2014). Somatic signature of brain-specific single nucleotide variations in sporadic Alzheimer's disease. J. Alzheimers. Dis. 42, 1357-1382. doi: 10.3233/JAD-140891
64. Pedraza, O., Allen, M., Jennette, K., Carrasquillo, M., Crook, J., Serie, D., et al. (2014). Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects. Alzheimers Dement 10, 205-213. doi: 10.1016/j.jalz.2013.01.016
65. Phillips, P. C. (2008). Epistasis-the essential role of gene interactions in the structure and evolution of genetic systems. Nat. Rev. Genet. 9, 855-867. doi: 10.1038/nrg2452
66. Plomin, R., Haworth, C. M., and Davis, O. S. (2009). Common disorders are quantitative traits. Nat. Rev. Genet. 10, 872-878. doi: 10.1038/nrg2670
67. Poduri, A., Evrony, G. D., Cai, X., and Walsh, C. A. (2013). Somatic mutation, genomic variation, and neurological disease. Science 341:1237758. doi: 10.1126/science.1237758
68. Ramanan, V. K., and Saykin, A. J. (2013). Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. Am. J. Neurodegener. Dis. 2, 145-175.
69. Raux, G., Guyant-Maréchal, L., Martin, C., Bou, J., Penet, C., Brice, A., et al. (2005). Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J. Med. Genet. 42, 793-795. doi: 10.1136/jmg.2005.033456
70. Rayaprolu, S., Mullen, B., Baker, M., Lynch, T., Finger, E., Seeley, W. W., et al. (2013). TREM2 in neurodegeneration: evidence for association of the p. R47H variant with frontotemporal dementia and Parkinson's disease. Mol. Neurodegener. 8, 19. doi: 10.1186/1750-1326-8-19
71. Rehen, S. K., Yung, Y. C., McCreight, M. P., Kaushal, D., Yang, A. H., Almeida, B. S., et al. (2005). Constitutional aneuploidy in the normal human brain. J. Neurosci. 25, 2176-2180. doi: 10.1523/JNEUROSCI.4560-04.2005
72. Reitz, C., and Mayeux, R. (2014). Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem. Pharmacol. 88, 640-651. doi: 10.1016/j.bcp.2013.12.024
73. Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., and Abeliovich, A. (2013). Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease. Nature 500, 45-50. doi: 10.1038/nature12415
74. Ridge, P. G., Mukherjee, S., Crane, P. K., Kauwe, J. S., and Alzheimer's Disease Genetics Consortium. (2013). Alzheimer's disease: analyzing the missing heritability. PLoS ONE 8:e79771. doi: 10.1371/journal.pone.0079771
75. Ritchie, M. D. (2015). Finding the epistasis needles in the genome-wide haystack. Methods Mol. Biol. 1253, 19-33. doi: 10.1007/978-1-4939-2155-3_2
76. Robson, K. J., Lehmann, D. J., Wimhurst, V. L., Livesey, K. J., Combrinck, M., and Merryweather-Clarke, A. T.et al. (2004). Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease. J. Med. Genet. 41, 261-265. doi: 10.1136/jmg.2003.015552
77. Sassi, C., Guerreiro, R., Gibbs, R., Ding, J., Lupton, M. K., Troakes, C., et al. (2014a). Exome sequencing identifies 2 novel presenilin 1 mutations (p. L166V and p.S230R) in British early-onset Alzheimer's disease. Neurobiol. Aging 35, 2422.e13-2422.e16. doi: 10.1016/j.neurobiolaging.2014.04.026
78. Sassi, C., Guerreiro, R., Gibbs, R., Ding, J., Lupton, M. K., Troakes, C., et al. (2014b). Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease. Neurobiol. Aging 35, 2881.e1-2881.e6. doi: 10.1016/j.neurobiolaging.2014.06.002
79. Shen, L., Thompson, P. M., Potkin, S. G., Bertram, L., Farrer, L. A., Foroud, T. M., et al. (2014). Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers. Brain Imag. Behav. 8, 183-207. doi: 10.1007/s11682-013-9262-z
80. Siest, G., Pillot, T., Régis-Bailly, A., Leininger-Muller, B., Steinmetz, J., Galteau, M. M., et al. (1995). Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin. Chem. 41(Pt 1), 1068-1086.
81. Slattery, C. F., Beck, J. A., Harper, L., Adamson, G., Abdi, Z., Uphill, J., et al. (2014). R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia. Alzheimers Dement 10, 602-608. doi: 10.1016/j.jalz.2014.05.1751
82. Sleegers, K., Brouwers, N., Gijselinck, I., Theuns, J., Goossens, D., Wauters, J., et al. (2006). APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain 129(Pt 11), 2977-2983. doi: 10.1093/brain/awl203
83. Sorbi, S., Nacmias, B., Forleo, P., Piacentini, S., Latorraca, S., and Amaducci, L. (1995). Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Ann. Neurol. 38, 124-127. doi: 10.1002/ana.410380120
84. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., et al. (1993). Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90, 1977-1981. doi: 10.1073/pnas.90.5.1977
85. Tomiyama, T., Nagata, T., Shimada, H., Teraoka, R., Fukushima, A., Kanemitsu, H., et al. (2008). A new amyloid β variant favoring oligomerization in Alzheimer's-type dementia. Ann. Neurol. 63, 377-387. doi: 10.1002/ana.21321
86. Wei, W. H., Hemani, G., and Haley, C. S. (2014). Detecting epistasis in human complex traits. Nat. Rev. Genet. 15, 722-733. doi: 10.1038/nrg3747
87. Wray, N. R., Yang, J., Hayes, B. J., Price, A. L., Goddard, M. E., and Visscher, P. M. (2013). Pitfalls of predicting complex traits from SNPs. Nat. Rev. Genet. 14, 507-515. doi: 10.1038/nrg3457